menu search

Roivant, pfizer shares rise as roche agrees to buy immunology company for $7.1 billion

Shares of Roivant Sciences Ltd. ROIV, -1.13% and Pfizer Inc. PFE, -1.73% gained ground premarket on Monday after Roche Holding AG RHHBY, +0.51% agreed...

October 23, 2023, 8:36 am

Roche (rhhby) nine months’ sales fall on lower covid-19 test sale

Roche’s rhhby performance in the third quarter and the first nine months of 2023 was impacted by a sh...

October 21, 2023, 1:59 am

Roche reports nine months sales growth despite lower sales from covid-19 products

Roche Holdings AG’s rhhby nine months sales increased by 1% (down 6% in CHF) to CHF 44.1 billion, eve...

October 19, 2023, 1:44 pm

Roche (rhhby) nine months' sales fall on lower covid-19 test sale

Roche (RHHBY) reports a sales decline in the first nine months of 2023 as COVID-19-test sales continue to dent its top line. Currency rate fluctuation...

October 19, 2023, 12:47 pm

Roche's (rhhby) ms drug reduces brain lesions in phase ii study

Roche (RHHBY) presents new data from a phase II study, which shows that fenebrutinib is brain penetrant and reduces brain lesions in people with relap...

October 16, 2023, 2:17 pm

Roche's (rhhby) vabysmo positive in late-stage rvo studies

Roche (RHHBY) Vabysmo maintains vision improvements with extended treatment intervals of up to four months in phase III studies for retinal vein occlu...

October 10, 2023, 1:32 pm

Genentech to present new key clinical and real-world data at ectrims-actrims 2023 showcasing strength of long-term outcomes in ms and nmosd

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), will present new data for Ocrevus®...

October 2, 2023, 1:00 am

Roche to present new key clinical and real-world data at ectrims-actrims 2023 showcasing strength of long-term outcomes in ms and nmosd

Basel, 02 October 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) will present new data for OCREVUS® (ocrelizumab) and investigational Bruton's tyrosine ki...

October 2, 2023, 1:00 am

Roche's (rhhby) application for pnh drug accepted by fda

Roche (RHHBY) biologics license application seeking approval for crovalimab for paroxysmal nocturnal hemoglobinuria gets FDA acceptance....

September 6, 2023, 10:32 am

Roche's (rhhby) late-stage lung cancer study meets primary goal

Roche's (RHHBY) late-stage ALK-positive non-small cell lung cancer study evaluating Alecensa meets the primary endpoint of disease-free survival....

September 1, 2023, 9:47 am

Roche's (rhhby) evrysdi gets label expansion in eu for newborns

Following the label expansion, Roche's (RHHBY) Evrysdi is now approved to treat people of all ages with SMA in the European Union....

August 29, 2023, 12:46 pm

Biotech stocks rally after roche's (rhhby) accidental data leak

Shares of several companies developing anti-TIGIT therapies rise after Roche (RHHBY) accidentally leaks encouraging late-stage study data....

August 24, 2023, 12:47 pm

Gilead, arcus, iteos, other biopharmas get boost from accidental disclosure of roche lung cancer trial data

Shares of biopharmaceutical companies developing anti-TIGIT cancer therapies, including Gilead Sciences Inc. GILD, +0.54%, Arcus Biosciences Inc. RCUS...

August 23, 2023, 8:45 am

Roche (rhhby) 1h revenues, earnings down on lower covid-19 test sales

Image Source: Zacks Investment Research The company reported total sales of CHF 14.4 billion in the second quarter of 2023, flat year over year. Sales...

July 27, 2023, 5:59 pm

Roche’s 1h earnings decline on lower covid-19 sales, cfo says late-stage pipeline has gaps that needs to be filled

Roche Holding AG (OTC: RHHBY) said sales for 1H 2023 dropped to CHF 30.62 billion from CHF 33.9 billion in the sam … Read Full Story at source (may ...

July 27, 2023, 3:59 pm

Roche holding ag (rhhby) q2 2023 earnings call transcript

Roche Holding AG (OTCQX:RHHBY) Q2 2023 Earnings Conference Call July 27, 2023 8:00 AM ET Company Participants Bruno Eschli - Head, Investor Relations ...

July 27, 2023, 3:55 pm

Roche (rhhby) 1h revenues, earnings down on lower covid-19 test sales

Roche's (RHHBY) performance in the first half of 2023 was ordinary as COVID-19-test sales continue to decline and dent the top line....

July 27, 2023, 1:57 pm

Roivant (roiv) up on reports of colitis drug sale to roche

Shares of Roivant ROIV rose almost 12% on Thursday after a Wall Street Journal (WSJ) article reported that Roche...

July 14, 2023, 12:39 pm

Roche (rhhby) blood cancer drug columvi wins ec approval

Roche's (RHHBY) blood cancer portfolio gets a boost with the EC's approval of Columvi (glofitamab-gxbm) for treating patients with R/R DLBCL....

July 11, 2023, 2:02 pm

Roche (rhhby) announces positive long-term data on sma drug

Roche's (RHHBY) SMA drug Evrysdi maintains its efficacy and safety profile in children with type 1 SMA after four years of treatment....

July 3, 2023, 12:57 pm


Search within

Pages Search Results: